Submission Preparation ChecklistAs part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- Verify if it is an original contribution, if the conflict of interest statement is included in the text, and if it fulfills your country's ethical requirements.
- Provide your ORCID number (only ORCID with open biography is accepted)
- Provide a cover letter containing institutional and funding information
- Check if the information about authors and affiliations in metadata is the same as described in the paper. Use the FULL NAME for all authors to prepare the cover letter and fill out the metadata form.
- Please be aware that the average time between the first submission and the final publication is 6 to 8 months. Delays could happen.
INSTRUCTIONS FOR AUTHORS
(Updated: 2023, October 30th)
The scope of the IJHDR is to publish high-quality studies (clinical, experimental, reviews) about the biological/physicochemical/clinical effects of highly diluted substances, including homeopathic preparations. Hypotheses only are not included in the scope.
IJHDR will consider original submissions that have not been published in any medium or submitted for publication elsewhere. Submissions derived from a "pre-print" publication or presentations at scientific meetings may be considered for publication even when they have been included in proceedings; the author(s) must make an explicit statement in this regard. The "pre-print" statement must be mentioned as a subtitle.
IJHDR is entitled to make alterations in submissions to meet the journal’s standards while keeping its style and contents.
Author(s) automatically agree with IJHDR policies from the initial submission.
IJHDR is a philanthropic initiative; thus, authors do not need to pay article processing charges (APC) or any other fee for submission.
THE SUBMISSION INCLUDES A) COMPLETE FILLING OF METADATA; B) UPLOAD OF THE ANONIMIZED MANUSCRIP AND THE ADDITIONAL FILES (TABLES AND FIGURES); C) THE TITLE PAGE WITH THE FOLLOWING MANDATORY ITEMS: TITLE, AUTHORS´ NAMES, AFFILIATIONS, FUNDING INFORMATION, CONFLICT OF INTEREST STATEMENT, AND A VALID ORCID NUMBER WITH DATA OPEN TO PUBLIC (please, see https://orcid.org/signin); D) THE COVER LETTER.
BEFORE SUBMITTING, PLEASE SEE THE CHECKLIST ABOVE.
THE LACK OF THIS INFORMATION CAN IMPAIR THE EDITORIAL FLOW TO THE REVIEWERS.
IJHDR considers submissions in the following categories:
- Original articles: resulting from empiric, experimental (including clinical trials), or conceptual original research;
- Review articles: a critical analysis of thorough and updated literature on topics related to the field of HD research;
- Letter to Editors: dealing with subjects relevant to HD research, not including original research or a thorough review of current literature. Opinion articles will be classified in this section if approved;
- Short communications: preliminary reports of research under progress;
- Case reports are a series of clinical cases exclusively aiming to discuss specific aspects that might contribute to research in HDs. Attention: single-case reports are not in the scope of the journal. Few exceptions can be considered in the function of the nature of the treated disease and the innovative impact of the results.
- Dissertation abstracts: structured abstract reporting the main results derived from an academic dissertation;
- Book review: no advertising.
- Announcements: information on scientific meetings or other news relevant to HD research.
IJHDR follows the Guidelines suggested by the International Committee of Medical Journal Editors (ICMJE); it is recommended to consult them. (www.icmje.org)
- The full submission process and correspondence between the author(s) and IJHDR is conducted exclusively online through the IJHDR website. Registration as “Author” is required for the submission process. All stages in the submission process can be followed online through the IJHDR website.
- All authors must register on the IJHDR website and inform all data required. Correspondence with IJHDR will be exclusively carried out by a “Correspondent Author” named by authors at the moment of initial submission. The "Correspondent Author" is responsible for inputting all data about the manuscript into the system.
- Submissions will be sent in English (American and British); author(s) are responsible for English grammar; it is recommended to consult an English native speaker or professional translator before submitting.
- Before submitting your manuscript, check if it is in full accordance with the ethical rules of your country. For Brazilian clinical studies in humans, the registration of any study on "Plataforma Brazil" is mandatory, even for case reports and series (according to the CONEP resolution 166/18 published on June 12, 2018).
PARTS OF SUBMISSION:
1. TITLE PAGE: Times New Roman 12; double space; non-justified; non-indented, containing:
- Journal Section corresponding the the subject of your manuscript.
- Title of submission: must be self-explanatory and accurately represent the submission contents. Please do not use caps lock only to write the title.
- For each author: full name; highest professional/academic degree; institutional affiliation (name of institution, city, country, website); e-mail; homepage; ORCID number. Authors must be listed in the final order in which they appear in the published article.
- Name of the corresponding author
- Abstract: must be structured whenever applicable (Background of the research Project; Aims; Methodology; Results; Conclusions); when not applicable, the abstract must give a thorough account of the same items. Abstracts must be 150-250 words long.
- Keywords: 3-5 words that best describe the submission contents, according to MeSH (http://www.nlm.nih.gov/mesh); DeCS (http://decs.bvs.br) or Homeopathic Thesaurus –ECH (www.homeopathyeurope.org)
- Statement of conflict of interest: Authors must declare whether there is any explicit or potential conflict of interest, including any financial, personal, direct, or indirect relationship with organizations that could somehow influence the work. Potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. When there is no conflict of interest, must declare “author(s) declare(s) there is no conflict of interest” (more details at http://www.icmje.org/#conflicts).
- Statement of financial support: author(s) must declare funds related to any step of research and elaboration of submission; when there is no funding, author(s) must declare “author(s) declare(s) that this study received no funding”. If the research has financial support, the Author(s) must declare: “ I (We) had full access to all the data in this study, and I (We) take complete responsibility for the integrity of the data and the accuracy of the data analysis.”
2. MANUSCRIPT FILE: Times New Roman 12; single space; non-justified; no indentation; no hyphenation, uploaded in Step 3 of the submission process, blinded and named “Main Text” containing:
- Title of submission (see above, “Front Page”)
- Abstract (see above, “Front Page”)
- Keywords (see above, “Front Page”)
- Text of submission (see below)
- References (see immediately below)
- Acknowledgments (optional)
- Fundings and conflict of interest statements
- List of graphic and table legends
3. COVER LETTER AND ADDITIONAL FILES
NEEDS FOR SUBMISSION TEXT - IMPORTANT DIRECTIVES:
- Footnotes will not be accepted.
- Abbreviations must be defined in the text upon first use.
- The rules of zoological and botanical nomenclature must be observed, as well as abbreviations and conventions adopted in specific disciplines.
- HD research also has its specific terminology. For this reason, we recommend not employing questionable terms that point out underlying scientific notions.
- Homeopathic remedies: must appear in italics; binomial system, abbreviations may be used from the second mention onward. Dilutions must be described in Arabic numbers (e.g., 6; 30; 200; 1,000; 10,000) followed by scale/method, as follows: decimal (x), centesimal (c), fifty-millesimal (lm), Hahnemannian (H), Korsakovian (K), continual fluxion (CF). Examples: 6cH; 30x; 200K; 1,000CF; 6lm. In all instances, the preparation process must be explicitly stated by mentioning the official Pharmacopoeia or full description.
- Submissions in the natural sciences must follow the standard structure of scientific publication: Introduction, Materials, and Methods; Results; Discussion; Conclusion. These two sections cannot be fused into one.
- Research involving living beings: Research involving human beings: publication is dependent on the observance of the ethical principles stated in the Helsinki Declaration of the World Medical Association (https://www.wma.net/what-we-d
o/medical-ethics/declaration-o f-helsinki/) and the local legislation of the country where the research was performed. The article must contain an explicit statement and approval from the Ethics Committee. Research involving animals: must respect ethical legislation, and explicit statements must be made of the standards adopted.
- Clinical trials: must include a CONSORT flow chart (www.consort-statement.org) and RedHot checklist (https://pubmed.ncbi.nlm.nih.g
ov/17200612/ or https://www.karger.com/Article /Abstract/97073). Clinical trials must be registered (http://www.icmje.org/faq_clinical.html). The Clinical Trial's base name and code/number must be stated at the end of the Abstract.
- Clinical reports and homeopathic pathogenetic trials: a) must include a RedHot checklist (www.redhot-homeopathy.info) or a CARE checklist (https://static1.squarespace.com/static/5db7b349364ff063a6c58ab8/t/5db7bf175f869e5812fd4293/1572323098501/CARE-checklist-English-2013.pdf); b) require formal patient consent. A model can be from https://www.schulich.uwo.ca/familymedicine/research/docs/resources/Patient%20Consent%20for%20Publication%20-%20Generic.pdf; c) for Brazilian clinical studies in humans, the registration of any study on "Plataforma Brazil" is mandatory, even for case reports and series (according to the CONEP resolution 166/18 published on June 12, 2018).
- General recommendations for writing clinical reports: IJHDR adopts the recommendations for Designing, Conducting, and Reporting Clinical Observational Studies in Homeopathic Human and Veterinary Medicine, as well as systematic review/meta-analysis studies available at WissHom website: https://www.wisshom.de/publikationen/anleitungen-homoeopathie-studien/. Alternatively, please see: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539417/REFERENCES:
- References must be kept within the minimum required; only citations in the text can be included.
- References must fit scientific standards. Citations of peer-reviewed media will be preferred; communications not available in a public source will be avoided as much as possible; references to previous work(s) of the author(s) published in non-peer-reviewed media will not be accepted.
- References must be up-to-date; in the natural sciences, this means at least a review of publications in peer-reviewed media of the previous 5 years.
- All references must be correct and complete. The author (s) is (are) responsible for accuracy.
- References must be consecutively numbered according to the text's citation order. Arabic numbers must identify them between brackets, e.g., ; [1,2]; [1-3]. References cited only in tables and graphics will follow the number of the last citation in the text.
- IJHDR has adopted the Vancouver standard of scientific citation. Examples are given below; we recommend consulting the following websites for a thorough explanation: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=citmed.TOC&depth=2 http://www.nlm.nih.gov/bsd/uniform_requirements.html
- The official abbreviation of journals can be found at http://www.nlm.nih.gov/tsd/serials/lji.html
- The most common examples are described below; for other cases, please consult the links mentioned above;
- Fields between < > do not apply in all cases;
- <Type> = “letter, abstract, editorial, dissertation, ...” (except “article”);
- <Electronic Medium> = “online, CDROM, …”;
- [language], whenever different from English.
- Author’s names are represented as “Surname ABC, ..., Surname WYZ”.
- Editors’ names are represented as “Surname2 ABC, ..., Surname2 WYZ”.
- All authors must be listed; avoid using “et al.” whenever possible.
- Dates must be cited “yyyy Mmm dd”, as e.g., “2009 Jan 24”;
- Fields preceded by “#” represent numbers (e.g. #Volume, #issue, #DOI, …);
- #From-#to refers to initial and final pages;
Authors. Article Title. Journal Title. Date of Publication; Volume (Issue): initial page-final page. <[Language]>.
Surname ABC, ..., Surname WYZ. Article title. Abbreviated Journal Name. yyyy Mmm dd; #volume (#issue <[Suppl #supplement]>): #from-#to. <[language].>
Varricchio MCBN, Pereira C, Sales F, Gomes T, Daudt E, Aquino CL, Barbosa GM, Gomes N, Pyrrho AS, Hobaica PEM, Branco MC, Kuster R, Holandino C. Chronic toxicological effects of high diluted solutions of Aveloz (Euphorbia tirucalli L.) on healthy mice: a preliminary study. Int J High Dilution Res. 2008; 7(25): 174-178.
Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev. 2005 Apr;85(2):679-715.
Gayer T, Hahn RW. Regulating mercury: what's at stake? [letter]. Science. 2005 Jul 8;309(5732):244-5.
Bechade D, Desrame J, Raynaud JJ, Algayres JP. [Oesophageal ulcer associated with the use of bacampicillin]. Presse Med. 2005 Feb 26;34(4):299-300. [French].
Obs: use “[ ]” for titles when translated into English.
Authors. Article Title. Journal Title [Electronic Medium]. Date of Publication [Date of Citation]; #Volume (#Issue): Pagination. Identifiers. Language, Availability
Surname ABC, .., Surname WYZ. Full Article's title <[type]>. Abbreviated Journal’s Name [serial online]. yyyy Mmm dd [cited YYYY Month dd]; #volume (#issue <[Suppl #supplement]>): <#from-#to.> <[about #n p.]> <[DOI #DOI];> <[Others identifiers].> <[language].> Available from: http://
Varricchio MCBN, Pereira C, Sales F, Gomes T, Daudt E, Aquino CL, Barbosa GM, Gomes N, Pyrrho AS, Hobaica PEM, Branco MC, Kuster R, Holandino C. Chronic toxicological effects of high diluted solutions of Aveloz (Euphorbia tirucalli L.) on healthy mice: a preliminary study. Int J High Dilution Res [serial online]. 2008 [cited 2009 Feb 10]; 7(25): 174-178. Available from:
Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial online]. 2002 Jun [cited 2002 Aug 12];102(6):[about 3 p.]. Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htm
Happell B. The influence of education on the career preferences of undergraduate nursing students. Aust Electron J Nurs Educ [serial online]. 2002 Apr [cited 2007 Jan 8];8(1):[about 12 p.]. Available from:
Treves R. [Dupuytren's disease]. Reumatismo [serial online]. 2006 Jul-Sep [cited 2007 Jan 10];58(3):239-42. [Italian] Available from: http://www.reumatismo.org/admin/filesArticoli/58-3-239.pdf
Authors. Title. Edition. Editors. Place of Publication: Publisher; Date of publication.
Surname ABC, …, Surname WYZ. Book title. #n th ed. Surname2 ABC, …, Surname2 WYZ, editors. City (Country): Publisher; year.
Signals and Images: contributions and contradictions about high dilution research. Bonamin LV, editor. London (UK): Springer; 2008.
Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, editors. Operative obstetrics. 2nd ed. New York: McGraw-Hill; 2002.
Eyre HJ, Lange DP, Morris LB. Informed decisions: the complete book of cancer diagnosis, treatment, and recovery. 2nd ed. Atlanta: American Cancer Society; 2002.
Authors. Article Title. Journal Title [Electronic Medium]. Place of Publication: Publisher; Date of Publication [Date of Citation]. Pagination. [Language]. Availability
Surname ABC, …, Surname WYZ. Book name. #n th ed. Surname2 ABC, …, Surname2 WYZ, editors. [book online]. City (Country): Publisher; year [cited yyyy Mmm DD]. [about #n p]. Available from: http://
Patrias, K. Citing medicine: the NLM style guide for authors, editors, and publishers [book online]. 2nd ed. Wendling, DL, technical editor. Bethesda (MD): National Library of Medicine (US); 2007 [updated 2009 Jan 14; cited 2009 Jan 28]. Available from: http://www.nlm.nih.gov/citingmedicine
Collins SR, Kriss JL, Davis K, Doty MM, Holmgren AL. Squeezed: why rising exposure to health care costs threatens the health and financial well-being of American families [book online]. New York: Commonwealth Fund; 2006 Sep [cited 2006 Nov 2]. 34 p. Available from:
Fact sheet: AIDS information resources [book online]. Bethesda (MD): National Library of Medicine (US); 2003 May 2 [updated 2005 Jul 14; cited 2006 Nov 15]. [about 3 screens]. Available from: http://www.nlm.nih.gov/pubs/factsheets/aidsinfs.html
Chapter in Book (printed):
Authors. Chapter Title. Editor name. Book Title. Edition. Place of Publication: Publisher; Date of Publication. Pagination.
Surname ABC, …, Surname WYZ. Chapter title. In: Surname2 ABC, …, Surname2 WYZ, editors. Book title. #n th ed. City (Country): Publisher; year. p. #from-#to.
Betti L, Trebbi G, Nani D, Majewsky V, Scherr C, Jäger T, Baumgartner S. Models with plants, microorganisms and viruses for basic research in homeopathy. In: Bonamin LV, editor. Signals and images: contributions and contradictions about high dilution research. New York (USA): Springer; 2008. p.97-112.
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.
Chapter in Book (online):
Authors. Chapter Title. Editor name. Book Title. Edition. [Electronic medium]. Place of Publication: Publisher; Date of Publication [Date of Citation]. Pagination. [Language]. Availability
Surname ABC, …, Surname WYZ. Chapter name. In: Surname2 ABC, …, Surname2 WYZ, editors. Book Title #n th ed. [book online]. City (Country): Publisher; year. [cited yyyy Month DD] #from-#to. [about #n p.] <[Language].> Available from: http://
Greenhalgh T. Meta-analysis for the non-statistician. In: How to read a paper: papers that summarise other papers (systematic reviews and meta-analyses) [book online]. London (UK):BMJ; 1997 [cited 2009 Feb 06] [about 1 p.] Available from http://www.bmj.com/cgi/content/full/315/7109/672#Meta-analysis_for_the_non-statistician
Editor(s). Book Title. Conference Title; Date of Conference; Place of Conference. Place of Publication: Publisher; Date of Publication. Pagination.
Surname2 ABC, …, Surname2 WYZ, editor(s). Conference title. Proceedings of the Conference’s name; yyyy Mmm dd- Mmm dd; City (Country). City (Country): Publisher; yyyy. #n p.
Ferreira de Oliveira MJ, editor. Accessibility and quality of health services. Proceedings of the 28th Meeting of the European Working Group on Operational Research Applied to Health Services (ORAHS); 2002 Jul 28-Aug 2; Rio de Janeiro (Brazil). Frankfurt (Germany): Peter Lang; 2004. 287 p.
Dittmar A, Beebe D, editors. 1st Annual International IEEE-EMBS Special Topic Conference on Microtechnologies in Medicine & Biology; 2000 Oct 12-14; Palais des Congres, Lyon (France). Piscataway (NJ): IEEE; 2000. 643 p.
Work in events:
Authors. Article Title. Editor(s). Event Title: Event Date; Place of Event. Place of Publication: Publisher; Date of Publication. Pagination
Surname ABC, …, Surname WYZ. Work Title. In: Surname2 ABC, …, Surname2 WYZ, editors. Proceedings of the Event Name; yyyy Mmm DD-DD; City ( Country). City (Country):Publisher; YYYY. p. #from-#to.
Rice AS, Farquhar-Smith WP, Bridges D, Brooks JW. Cannabinoids and pain. In: Dostorovsky JO, Carr DB, Koltzenburg M, editors. Proceedings of the 10th World Congress on Pain; 2002 Aug 17-22; San Diego, CA. Seattle (WA): IASP Press; c2003. p. 437-68.
Kim H, Wechsler B. Amantadine for arousal in pediatric TBI. In: Peek WJ, Lankhorst GJ, editors. 1st World Congress of the International Society of Physical and Rehabilitation Medicine (ISPRM I); 2001 Jul 7-13; Amsterdam (The Netherlands). Bologna (Italy): Monduzzi Editore, International Proceedings Division; c2001. p. 629-34.
Monographs and Dissertations:
Authors. Title [type]. Place of Publication: Publisher; Date of presentation. Pagination.
Surname ABC, ..., Surname WYZ. Title of Document [dissertation]. City (Country): Publisher; yyyy Mmm dd. #n p.
Miranda AR. Comparative studies of ultra-high dilutions of LiCl: impedance spectroscopy in the frequency range of 1kHz to 13MHz [dissertation]. São Paulo (Brazil): Institute of Physics, University of São Paulo; 2008. 127p.
Monographs and Dissertations (online):
Authors. Title [type]. Place of Publication: Publisher; Date of presentation. Date of Citation. Pagination. Availability
Surname ABC, ..., Surname WYZ. Title of Document [dissertation online]. City (Country): Publisher; yyyy Mmm dd [cited yyyy Mmm dd] [about #n p.]. Available from: http://
Collins SR, Kriss JL, Davis K, Doty MM, Holmgren AL. Squeezed: why rising exposure to health care costs threatens American families' health and financial well-being [monograph online]. New York: Commonwealth Fund; 2006 Sep [cited 2006 Nov 2]. 34 p. Available from:
Fact sheet: AIDS information resources [monograph online]. Bethesda (MD): National Library of Medicine (US); 2003 May 2 [updated 2005 Jul 14; cited 2006 Nov 15]. [about 3 screens]. Available from: http://www.nlm.nih.gov/pubs/factsheets/aidsinfs.html
Zieger K. Die Bedeutung der deutschen Arztevereine fur das wissenschaftliche Leben, die medizinische Versorgung und soziale Belange der Stadt St. Petersburg von 1819-1914 [dissertation online]. Leipzig (Germany): Universitat Leipzig, Karl-Sudhoff-Institut fur Geschichte der Medizin und der Naturwissenschaften; 2000 [cited 2006 Nov 3]. 123 p. Available from: http://www.vifaost.de/w/pdf/zieger-aerzte.pdf [German].
Author, Title [Type]. Place of Publication: Publisher; Date of Publication [Date of Update/Revision; Date of Citation]. Availability
Surname ABC, …, Surname WYZ. Title [online]. City (country): Publisher; yyyy [updated yyyy Mnn dd; cited yyyy Mnn dd]. Available from: http://
Complementary/Integrative Medicine [online]. Houston: University of Texas, M. D. Anderson Cancer Center; c2007 [cited 2007 Feb 21]. Available from: http://www.mdanderson.org/departments/CIMER/
D'Alessandro DM, D'Alessandro MP. Virtual Pediatric Hospital™: a digital library of pediatric information [online]. [Iowa City (IA)]: Donna M. D'Alessandro; c1992-2007 [revised 2006 Jul 20; cited 2007 Feb 20]. Available from: http://www.virtualpediatrichospital.org/
Huckstep RL, Sherry E. World Ortho [online]. [place unknown: publisher unknown]; [updated 2007 Mar 23; cited 2007 Mar 23]. Available from: http://www.worldortho.com/
3. GRAPHICS AND TABLES
- Every graphic and table will be uploaded in a separate file as Supplementary File in Step 4 of the submission process, each named as described in the list of graphics and table legends (Graphic 2; Table 1, etc.)
- Digitalized images must attend to the following: resolution 400dpi in natural size, saved in JPG, GIF, or PNG formats.
- Graphics and Tables must be self-explanatory and present relevant data in an immediately evident way.
- IJHDR encourages the use of graphic and multimedia resources.
- Select Section; Checklist for Authors; Copyright Agreement; Comments to Editor (stating why the submission is relevant to HD research and what its potential contribution to the development of the field of HD research is).
- Enter Submission Metadata: data on the author(s) must be thoroughly and accurately filled in for each author; the submission title; abstract; keywords; and classification data.
- Enter Submission: upload the blinded submission text (see details here), with title, abstract, main text, references, list of graphics and tables legends, and acknowledgments (optional).
- Supplementary Materials: Front Page; Graphics, Tables, and other Audiovisual files (individual files for each one; files named as described in the list of graphic and table legends, (e.g., Figure 3; Table 1; Video 2, etc.)
- Confirm Submission.
- Each submission is pre-evaluated by the Editorial Team according to the scope and submission rules of the Journal. If approved, it follows the editorial flow on a double-blind basis, in which two to three ad-hoc reviewers with expertise in the area related to the paper subject are invited to evaluate, following a structured form and using the submission guideline as reference. The homeopathy practice is optional for a reviewer, but a scientific background is needed. After all reviewers' approval, the paper will be submitted to the final Editorial staff evaluation before publication.
- Further inconsistencies of results and ethical procedures identified after publication will imply the publication of an erratum by the authors in the following issue or, if necessary, the paper's retraction. The Editorial Board will be consulted to reach a consensus in these cases.
Conference PresentationReserved to event Proceedings only
ProceedingsReserved to event's proceedings only
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.